| Target and Pathway |
Top |
| Target(s) |
Matrix metalloproteinase-1 (MMP-1) |
Target Info
|
Inhibitor |
[1] |
| Matrix metalloproteinase-13 (MMP-13) |
Target Info
|
Inhibitor |
[1] |
| Matrix metalloproteinase-2 (MMP-2) |
Target Info
|
Inhibitor |
[1] |
| Matrix metalloproteinase-9 (MMP-9) |
Target Info
|
Inhibitor |
[1] |
| Target's Patent Info |
Matrix metalloproteinase-1 (MMP-1) |
Target's Patent Info
|
[1] |
| Matrix metalloproteinase-13 (MMP-13) |
Target's Patent Info
|
[1] |
| Matrix metalloproteinase-2 (MMP-2) |
Target's Patent Info
|
[1] |
| Matrix metalloproteinase-9 (MMP-9) |
Target's Patent Info
|
[1] |
|
KEGG Pathway
|
PPAR signaling pathway
|
|
Pathways in cancer
|
|
Bladder cancer
|
|
Rheumatoid arthritis
|
|
TNF signaling pathway
|
|
Leukocyte transendothelial migration
|
|
Estrogen signaling pathway
|
|
Hepatitis B
|
|
Transcriptional misregulation in cancer
|
|
Proteoglycans in cancer
|
|
MicroRNAs in cancer
|
|
GnRH signaling pathway
|
|
NetPath Pathway
|
IL1 Signaling Pathway
|
|
EGFR1 Signaling Pathway
|
|
TWEAK Signaling Pathway
|
|
Wnt Signaling Pathway
|
|
ID Signaling Pathway
|
|
Leptin Signaling Pathway
|
|
TNFalpha Signaling Pathway
|
|
TCR Signaling Pathway
|
|
Panther Pathway
|
Alzheimer disease-presenilin pathway
|
|
Plasminogen activating cascade
|
|
CCKR signaling map ST
|
|
Pathway Interaction Database
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
|
Endothelins
|
|
Validated transcriptional targets of AP1 family members Fra1 and Fra2
|
|
Glucocorticoid receptor regulatory network
|
|
AP-1 transcription factor network
|
|
Syndecan-1-mediated signaling events
|
|
LPA receptor mediated events
|
|
Plasma membrane estrogen receptor signaling
|
|
Osteopontin-mediated events
|
|
Validated targets of C-MYC transcriptional activation
|
|
CXCR4-mediated signaling events
|
|
amb2 Integrin signaling
|
|
Syndecan-4-mediated signaling events
|
|
Regulation of nuclear beta catenin signaling and target gene transcription
|
|
FGF signaling pathway
|
|
Angiopoietin receptor Tie2-mediated signaling
|
|
Direct p53 effectors
|
|
ATF-2 transcription factor network
|
|
FOXM1 transcription factor network
|
|
Syndecan-2-mediated signaling events
|
|
Reactome
|
Collagen degradation
|
|
Degradation of the extracellular matrix
|
|
Activation of Matrix Metalloproteinases
|
|
Assembly of collagen fibrils and other multimeric structures
|
|
Basigin interactions
|
|
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
|
EPH-ephrin mediated repulsion of cells
|
|
WikiPathways
|
Endochondral Ossification
|
|
Activation of Matrix Metalloproteinases
|
|
Oncostatin M Signaling Pathway
|
|
AGE/RAGE pathway
|
|
Matrix Metalloproteinases
|
|
TGF beta Signaling Pathway
|
|
Bladder Cancer
|
|
Degradation of collagen
|
|
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
|
|
Prostate Cancer
|
|
Integrated Breast Cancer Pathway
|
|
Integrated Cancer pathway
|
|
Cell surface interactions at the vascular wall
|
|
IL1 and megakaryotyces in obesity
|
|
Mammary gland development pathway - Involution (Stage 4 of 4)
|
|
Spinal Cord Injury
|
|
TWEAK Signaling Pathway
|
|
Angiogenesis
|
|
Osteopontin Signaling
|
